FARMINGTON, Conn.–(BUSINESS WIRE)–Corbin Advisors, a strategic consultancy accelerating value realization globally, announced Kristen Phillips has…
VaxALPR integrated for use on i-PRO AI cameras reduces hardware costs and project complexity. Amsterdam,…
Award presented by Juniper Research for ability to positively address telecommunications providers’ security challenges BEDFORD,…
PortalGuard Wins Gold in Multi-factor Authentication, Identity and Access Management, and Single Sign-On Categories; Identity-Bound…
RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage…
License Provides Steep Hill California Lab with Greatly Expanded Service Offering LAS VEGAS, NV, Feb….
SAN DIEGO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer…
ZUG, Switzerland, Feb. 09, 2022 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company focused…
Following discontinuation of ERT, AGA activity was stable at 14-fold mean normal level through week…
BUFFALO, N.Y., Feb. 09, 2022 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
SAN FRANCISCO, Feb. 09, 2022 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical…
WATERTOWN, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical…
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…
PALO ALTO, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical…
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST),…
Accomplished global biopharmaceutical executive with over 20 years of strategic and operational leadership at Bristol…
Cambridge, Massachusetts, Feb. 09, 2022 (GLOBE NEWSWIRE) — Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or…